Cargando…
Could Sars-Cov2 affect MS progression?
A long-term neurologic sequela arising from COVID-19 infection in multiple sclerosis (MS) patients could be related both to the increase of cytokines and the activation of NLRP3 inflammasome by the Sars-CoV2. These two mechanisms may cause a worsening of MS several months after the resolution of the...
Autores principales: | Di Stadio, Arianna, Romani, Luigina, Bernitsas, Evanthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524432/ https://www.ncbi.nlm.nih.gov/pubmed/33032060 http://dx.doi.org/10.1016/j.msard.2020.102540 |
Ejemplares similares
-
Nasal Microbiota and Neuroinflammation: Relationship between Nasal Flora and Multiple Sclerosis Onset/Progression
por: Gioacchini, Federico Maria, et al.
Publicado: (2022) -
The Microbiota/Host Immune System Interaction in the Nose to Protect from COVID-19
por: Di Stadio, Arianna, et al.
Publicado: (2020) -
Could breath analysis by MS could be a solution to rapid, non-invasive testing for COVID-19?
por: Walker, Heather J, et al.
Publicado: (2020) -
Temelimab for MS and SARS-CoV-2: Could it be a double-edged blessing?
por: Mouliou, Dimitra S., et al.
Publicado: (2022) -
Auditory Disturbances and SARS-CoV-2 Infection: Brain Inflammation or Cochlear Affection? Systematic Review and Discussion of Potential Pathogenesis
por: De Luca, Pietro, et al.
Publicado: (2021)